---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018877"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:55:21.188818+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# CEO Vuong Trieu presented at LD Micro conference on Oct 21; specifics not disclosed in filing

## Summary
- CEO Vuong Trieu presented a corporate presentation at LD Micro in San Diego on October 21, 2025.
- Exhibit 99.1 containing the presentation is attached but its content was not reproduced in this filing.
- No financial results, clinical updates, or guidance changes were provided in the 8-K text.
- This is a procedural 8.01 announcement of an investor presentation; no material operational detail.

## SEC filing metadata
- accession: 0001493152-25-018877
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/0001493152-25-018877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018877
- JSON: https://secwatch.observer/filing/0001493152-25-018877.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018877.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.